BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25674288)

  • 1. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature.
    Okoye E; Choi EK; Divatia M; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(12):9061-6. PubMed ID: 25674288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
    Tzou KY; Cheng WH; Lee WH; Ho CH
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of neuroendocrine carcinoma of the gallbladder.
    Chen H; Shen YY; Ni XZ
    World J Gastroenterol; 2014 Sep; 20(33):11916-20. PubMed ID: 25206300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
    Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
    J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
    Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
    World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.
    Colarossi C; Pino P; Giuffrida D; Aiello E; Costanzo R; Martinetti D; Memeo L
    Diagn Pathol; 2013 Feb; 8():19. PubMed ID: 23379295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
    Song W; Chen W; Zhang S; Peng J; He Y
    Diagn Pathol; 2012 Nov; 7():163. PubMed ID: 23186166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
    Slovin SF
    Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection.
    Watanabe M; Yamada Y; Kato H; Imai H; Nakano H; Araki T; Shiraishi T
    Pathol Int; 2002 Dec; 52(12):777-83. PubMed ID: 12588447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Pure" primary large cell neuroendocrine carcinoma of the urinary bladder: case report, literature review and diagnostic criteria.
    Pusiol T; Morichetti D; Zorzi MG
    Pathologica; 2014 Jun; 106(2):82-5. PubMed ID: 25291874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.
    Sasatomi E; Nalesnik MA; Marsh JW
    World J Gastroenterol; 2013 Jul; 19(28):4616-23. PubMed ID: 23901240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
    Ling C; Shen Y
    J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; MoliniƩ V; Theis D; SouliƩ M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced carcinoma of the prostatic urethra in a patient with marked response to chemotherapy, leading to preservation of the bladder.
    Hamasaki T; Kondo Y; Ogata Y; Yoshida K; Kimura G; Shimizu H; Nishimura T
    Int J Clin Oncol; 2010 Feb; 15(1):109-11. PubMed ID: 20087614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal metastasis from prostate cancer.
    Cante D; Franco P; Sciacero P; Girelli G; Casanova Borca V; Pasquino M; Migliaccio F; Tofani S; Grassi L; Marra A; Ozzello F; La Porta MR; Ricardi U
    Tumori; 2013; 99(1):6e-10e. PubMed ID: 23549020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental carcinoma of the prostate: significance of staging transurethral resection.
    Carroll PR; Leitner TC; Yen TS; Watson RA; Williams RD
    J Urol; 1985 May; 133(5):811-4. PubMed ID: 3989921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review.
    Cerulli C; Busetto GM; Antonini G; Giovannone R; Di Placido M; Soda G; De Berardinis E; Gentile V
    Urol Int; 2012; 88(3):365-9. PubMed ID: 22236613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.